Correspondence 0001437749-23-032039 from BioCardia, Inc. (BCDA)
BioCardia, Inc.
Date: Nov. 14, 2023 · CIK: 0000925741 · Accession: 0001437749-23-032039
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-275099
Letter
bcda20231114_corresp.htm
BioCardia, Inc.
320 Soquel Way
Sunnyvale, California 94085
November 14, 2023
VIA EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Attention: Cindy Polynice
Re: BioCardia, Inc.
Registration Statement on Form S-3
File No. 333-275099
Acceleration Request
Requested Date: November 16, 2023
Requested Time: 4:00 p.m.
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act of 1933, as amended, BioCardia, Inc. (the “Company”) hereby requests that the above-referenced Registration Statement on Form S-3 (File No. 333-275099) (the “Registration Statement”) be declared effective at the “Requested Date” and “Requested Time” set forth above, or as soon thereafter as practicable, or at such later time as the Company or its counsel may orally request via telephone call to the staff of the Division of Corporation Finance of the Securities and Exchange Commission. Once the Registration Statement has been declared effective, please orally confirm that event with the Company’s counsel, Wilson Sonsini Goodrich & Rosati, P.C., by calling Michael J. Danaher at (650) 320-4625.
[Signature page follows]
Sincerely,
BioCardia, Inc.
Show Raw Text
CORRESP 1 filename1.htm bcda20231114_corresp.htm BioCardia, Inc. 320 Soquel Way Sunnyvale, California 94085 November 14, 2023 VIA EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Attention: Cindy Polynice Re: BioCardia, Inc. Registration Statement on Form S-3 File No. 333-275099 Acceleration Request Requested Date: November 16, 2023 Requested Time: 4:00 p.m. Ladies and Gentlemen: Pursuant to Rule 461 under the Securities Act of 1933, as amended, BioCardia, Inc. (the “Company”) hereby requests that the above-referenced Registration Statement on Form S-3 (File No. 333-275099) (the “Registration Statement”) be declared effective at the “Requested Date” and “Requested Time” set forth above, or as soon thereafter as practicable, or at such later time as the Company or its counsel may orally request via telephone call to the staff of the Division of Corporation Finance of the Securities and Exchange Commission. Once the Registration Statement has been declared effective, please orally confirm that event with the Company’s counsel, Wilson Sonsini Goodrich & Rosati, P.C., by calling Michael J. Danaher at (650) 320-4625. [Signature page follows] Sincerely, BioCardia, Inc. /s/ Peter Altman Peter Altman President and Chief Executive Officer and Director cc: David McClung, BioCardia, Inc. Michael J. Danaher, Wilson Sonsini Goodrich & Rosati, P.C. Austin D. March, Wilson Sonsini Goodrich & Rosati, P.C.